Selected research
Industry Research
Retrovirus Service Industry Research Report 2026
Market perspective
The global Retrovirus Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Retrovirus Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Retrovirus Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Retrovirus Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Retrovirus Service include Charles River Laboratories, FenicsBio, Syd Labs, BiCell Scientific, Creative Biolabs, Labtoo, Creative Biogene, Genezen and Applied Biological Materials Inc. (abm), among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Retrovirus Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Retrovirus Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Retrovirus Service Market by Company
Charles River Laboratories
FenicsBio
Syd Labs
BiCell Scientific
Creative Biolabs
Labtoo
Creative Biogene
Genezen
Applied Biological Materials Inc. (abm)
Takara Bio USA, Inc
Cellomics Technology, LLC
AcceGen
ALSTEM
BioInnovatise
VectorBuilder
AMSBIO
Creative Biomart
Gentaur Genprice
Luzen SCI Co., Ltd
Retrovirus Service Segment by Type
Retrovirus Packaging Services
Retrovirus Production Services
Others
Retrovirus Service Segment by Application
Gene Therapy
Basic Biology Research
Others
Retrovirus Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Retrovirus Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Retrovirus Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Retrovirus Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Retrovirus Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Retrovirus Packaging Services
- Retrovirus Production Services
- Others
Applications
- Gene Therapy
- Basic Biology Research
- Others
Companies covered
- Charles River Laboratories
- FenicsBio
- Syd Labs
- BiCell Scientific
- Creative Biolabs
- Labtoo
- Creative Biogene
- Genezen
- Applied Biological Materials Inc. (abm)
- Takara Bio USA, Inc
- Cellomics Technology, LLC
- AcceGen
- ALSTEM
- BioInnovatise
- VectorBuilder
- AMSBIO
- Creative Biomart
- Gentaur Genprice
- Luzen SCI Co., Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Retrovirus Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Retrovirus Packaging Services
- 2.2.3 Retrovirus Production Services
- 2.2.4 Others
- 2.3 Retrovirus Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Gene Therapy
- 2.3.3 Basic Biology Research
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Retrovirus Service Breakdown Data by Type
- 3.1 Global Retrovirus Service Historic Market Size by Type (2021-2026)
- 3.2 Global Retrovirus Service Forecasted Market Size by Type (2027-2032)
4 Retrovirus Service Breakdown Data by Application
- 4.1 Global Retrovirus Service Historic Market Size by Application (2021-2026)
- 4.2 Global Retrovirus Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Retrovirus Service Market Perspective (2021-2032)
- 5.2 Global Retrovirus Service Growth Trends by Region
- 5.2.1 Global Retrovirus Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Retrovirus Service Historic Market Size by Region (2021-2026)
- 5.2.3 Retrovirus Service Forecasted Market Size by Region (2027-2032)
- 5.3 Retrovirus Service Market Dynamics
- 5.3.1 Retrovirus Service Industry Trends
- 5.3.2 Retrovirus Service Market Drivers
- 5.3.3 Retrovirus Service Market Challenges
- 5.3.4 Retrovirus Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Retrovirus Service Players by Revenue
- 6.1.1 Global Top Retrovirus Service Players by Revenue (2021-2026)
- 6.1.2 Global Retrovirus Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Retrovirus Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Retrovirus Service Head Office and Area Served
- 6.4 Global Retrovirus Service Players, Product Type & Application
- 6.5 Global Retrovirus Service Manufacturers Established Date
- 6.6 Global Retrovirus Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Retrovirus Service Market Size (2021-2032)
- 7.2 North America Retrovirus Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Retrovirus Service Market Size by Country (2021-2026)
- 7.4 North America Retrovirus Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Retrovirus Service Market Size (2021-2032)
- 8.2 Europe Retrovirus Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Retrovirus Service Market Size by Country (2021-2026)
- 8.4 Europe Retrovirus Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Retrovirus Service Market Size (2021-2032)
- 9.2 Asia-Pacific Retrovirus Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Retrovirus Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Retrovirus Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Retrovirus Service Market Size (2021-2032)
- 10.2 South America Retrovirus Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Retrovirus Service Market Size by Country (2021-2026)
- 10.4 South America Retrovirus Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Retrovirus Service Market Size (2021-2032)
- 11.2 Middle East & Africa Retrovirus Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Retrovirus Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Retrovirus Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Charles River Laboratories
- 12.1.1 Charles River Laboratories Company Information
- 12.1.2 Charles River Laboratories Business Overview
- 12.1.3 Charles River Laboratories Revenue in Retrovirus Service Business (2021-2026)
- 12.1.4 Charles River Laboratories Retrovirus Service Product Portfolio
- 12.1.5 Charles River Laboratories Recent Developments
- 12.2 FenicsBio
- 12.2.1 FenicsBio Company Information
- 12.2.2 FenicsBio Business Overview
- 12.2.3 FenicsBio Revenue in Retrovirus Service Business (2021-2026)
- 12.2.4 FenicsBio Retrovirus Service Product Portfolio
- 12.2.5 FenicsBio Recent Developments
- 12.3 Syd Labs
- 12.3.1 Syd Labs Company Information
- 12.3.2 Syd Labs Business Overview
- 12.3.3 Syd Labs Revenue in Retrovirus Service Business (2021-2026)
- 12.3.4 Syd Labs Retrovirus Service Product Portfolio
- 12.3.5 Syd Labs Recent Developments
- 12.4 BiCell Scientific
- 12.4.1 BiCell Scientific Company Information
- 12.4.2 BiCell Scientific Business Overview
- 12.4.3 BiCell Scientific Revenue in Retrovirus Service Business (2021-2026)
- 12.4.4 BiCell Scientific Retrovirus Service Product Portfolio
- 12.4.5 BiCell Scientific Recent Developments
- 12.5 Creative Biolabs
- 12.5.1 Creative Biolabs Company Information
- 12.5.2 Creative Biolabs Business Overview
- 12.5.3 Creative Biolabs Revenue in Retrovirus Service Business (2021-2026)
- 12.5.4 Creative Biolabs Retrovirus Service Product Portfolio
- 12.5.5 Creative Biolabs Recent Developments
- 12.6 Labtoo
- 12.6.1 Labtoo Company Information
- 12.6.2 Labtoo Business Overview
- 12.6.3 Labtoo Revenue in Retrovirus Service Business (2021-2026)
- 12.6.4 Labtoo Retrovirus Service Product Portfolio
- 12.6.5 Labtoo Recent Developments
- 12.7 Creative Biogene
- 12.7.1 Creative Biogene Company Information
- 12.7.2 Creative Biogene Business Overview
- 12.7.3 Creative Biogene Revenue in Retrovirus Service Business (2021-2026)
- 12.7.4 Creative Biogene Retrovirus Service Product Portfolio
- 12.7.5 Creative Biogene Recent Developments
- 12.8 Genezen
- 12.8.1 Genezen Company Information
- 12.8.2 Genezen Business Overview
- 12.8.3 Genezen Revenue in Retrovirus Service Business (2021-2026)
- 12.8.4 Genezen Retrovirus Service Product Portfolio
- 12.8.5 Genezen Recent Developments
- 12.9 Applied Biological Materials Inc. (abm)
- 12.9.1 Applied Biological Materials Inc. (abm) Company Information
- 12.9.2 Applied Biological Materials Inc. (abm) Business Overview
- 12.9.3 Applied Biological Materials Inc. (abm) Revenue in Retrovirus Service Business (2021-2026)
- 12.9.4 Applied Biological Materials Inc. (abm) Retrovirus Service Product Portfolio
- 12.9.5 Applied Biological Materials Inc. (abm) Recent Developments
- 12.10 Takara Bio USA, Inc
- 12.10.1 Takara Bio USA, Inc Company Information
- 12.10.2 Takara Bio USA, Inc Business Overview
- 12.10.3 Takara Bio USA, Inc Revenue in Retrovirus Service Business (2021-2026)
- 12.10.4 Takara Bio USA, Inc Retrovirus Service Product Portfolio
- 12.10.5 Takara Bio USA, Inc Recent Developments
- 12.11 Cellomics Technology, LLC
- 12.11.1 Cellomics Technology, LLC Company Information
- 12.11.2 Cellomics Technology, LLC Business Overview
- 12.11.3 Cellomics Technology, LLC Revenue in Retrovirus Service Business (2021-2026)
- 12.11.4 Cellomics Technology, LLC Retrovirus Service Product Portfolio
- 12.11.5 Cellomics Technology, LLC Recent Developments
- 12.12 AcceGen
- 12.12.1 AcceGen Company Information
- 12.12.2 AcceGen Business Overview
- 12.12.3 AcceGen Revenue in Retrovirus Service Business (2021-2026)
- 12.12.4 AcceGen Retrovirus Service Product Portfolio
- 12.12.5 AcceGen Recent Developments
- 12.13 ALSTEM
- 12.13.1 ALSTEM Company Information
- 12.13.2 ALSTEM Business Overview
- 12.13.3 ALSTEM Revenue in Retrovirus Service Business (2021-2026)
- 12.13.4 ALSTEM Retrovirus Service Product Portfolio
- 12.13.5 ALSTEM Recent Developments
- 12.14 BioInnovatise
- 12.14.1 BioInnovatise Company Information
- 12.14.2 BioInnovatise Business Overview
- 12.14.3 BioInnovatise Revenue in Retrovirus Service Business (2021-2026)
- 12.14.4 BioInnovatise Retrovirus Service Product Portfolio
- 12.14.5 BioInnovatise Recent Developments
- 12.15 VectorBuilder
- 12.15.1 VectorBuilder Company Information
- 12.15.2 VectorBuilder Business Overview
- 12.15.3 VectorBuilder Revenue in Retrovirus Service Business (2021-2026)
- 12.15.4 VectorBuilder Retrovirus Service Product Portfolio
- 12.15.5 VectorBuilder Recent Developments
- 12.16 AMSBIO
- 12.16.1 AMSBIO Company Information
- 12.16.2 AMSBIO Business Overview
- 12.16.3 AMSBIO Revenue in Retrovirus Service Business (2021-2026)
- 12.16.4 AMSBIO Retrovirus Service Product Portfolio
- 12.16.5 AMSBIO Recent Developments
- 12.17 Creative Biomart
- 12.17.1 Creative Biomart Company Information
- 12.17.2 Creative Biomart Business Overview
- 12.17.3 Creative Biomart Revenue in Retrovirus Service Business (2021-2026)
- 12.17.4 Creative Biomart Retrovirus Service Product Portfolio
- 12.17.5 Creative Biomart Recent Developments
- 12.18 Gentaur Genprice
- 12.18.1 Gentaur Genprice Company Information
- 12.18.2 Gentaur Genprice Business Overview
- 12.18.3 Gentaur Genprice Revenue in Retrovirus Service Business (2021-2026)
- 12.18.4 Gentaur Genprice Retrovirus Service Product Portfolio
- 12.18.5 Gentaur Genprice Recent Developments
- 12.19 Luzen SCI Co., Ltd
- 12.19.1 Luzen SCI Co., Ltd Company Information
- 12.19.2 Luzen SCI Co., Ltd Business Overview
- 12.19.3 Luzen SCI Co., Ltd Revenue in Retrovirus Service Business (2021-2026)
- 12.19.4 Luzen SCI Co., Ltd Retrovirus Service Product Portfolio
- 12.19.5 Luzen SCI Co., Ltd Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst